AZAndrew Zhang

Andrew Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Andrew Zhang has a total of 76 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Mobile Stroke Units Enable Hyperacute Interventions for Intracerebral Hemorrhage

    by Casandra MacLeod, Andrew Zhang, Nicolas Thompson, Elham Askari, Merry Huang, Nicholas Koroneos, Maureen Buttrick, Johnny Dang, Stella Chin, Chelsea Smith, et al.

    BACKGROUND: Mobile stroke units (MSUs) aim to expedite acute stroke management when compared with conventional emergency medical services (EMS). Despite the growing body of evidence surrounding MSUs and acute ischemic stroke, experience with intracerebral hemorrhage (ICH) in MSUs has been lacking. We aimed to evaluate the impact of MSU transportation, compared with EMS, on times to diagnosis and goal-directed treatment in patients with ICH. METHODS: Retrospective analysis of patients with acute ICH triaged by MSU or EMS from January 2018 to December 2022 was performed at 2 tertiary institutions, the Cleveland Clinic (OH) and Stony Brook University (NY). In the EMS cohort, only patients seen between 08:00 and 20:00, corresponding to the operating hours of MSU, were included. Primary outcomes included diagnosis by computed tomography, administration of antihypertensives, and time to goal systolic blood pressure (β =0.72 [95% CI, 0.62–0.82]; P β , 0.46 [95% CI, 0.36–0.59]; P P <0.001). CONCLUSIONS: MSUs provide faster diagnosis and medical treatment for patients with acute ICH than patients transported by conventional EMS.

  • Patterns and Predictors of Extra-Corporeal Membrane Oxygenation Related Cerebral Microbleeds

    by Karan Topiwala, Haitham Hussein, Kamran Masood, Andrew Zhang, Bhavani Kashyap, Jason Bartos, Huseyin Tore, Eva Mistry, Bentho Oladi, Bharathi Jagadeesan, et al.


  • Open Access

    Infarct Volume Predicts Hospitalization Costs in Anterior Circulation Large-Vessel Occlusion Stroke

    by C.D. Streib, S. Rangaraju, D.T. Campbell, D.G. Winger, S.L. Paolini, A.J. Zhang, B.T. Jankowitz, A.P. Jadhav, T.G. Jovin

    BACKGROUND AND PURPOSE: Anterior circulation large-vessel occlusion stroke, one of the most devastating stroke subtypes, is associated with substantial economic burden. We aimed to identify predictors of increased acute care hospitalization costs associated with anterior circulation large-vessel occlusion stroke. MATERIALS AND METHODS: Comprehensive cost-tracking software was used to calculate acute care hospitalization costs for patients with anterior circulation large-vessel occlusion stroke admitted July 2012 to October 2014. Patient demographics and stroke characteristics were analyzed, including final infarct volume on follow-up neuroimaging. Predictors of hospitalization costs were determined using multivariable linear regression including subgroup cost analyses by treatment technique (endovascular, IV tPA-only, and no reperfusion therapy) and sensitivity analyses incorporating patients initially excluded due to early withdrawal of care. RESULTS: Three hundred forty-one patients (median age, 69 years; interquartile range, 57–80 years; median NIHSS score, 16; interquartile range, 13–21) were included in our primary analysis. Final infarct volume, parenchymal hematoma, baseline NIHSS score, ipsilateral carotid stenosis, age, and obstructive sleep apnea were significant predictors of acute care hospitalization costs. Final infarct volume alone accounted for 20.87% of the total cost variance. Additionally, final infarct volume was consistently the strongest predictor of increased cost in primary, subgroup, and sensitivity analyses. CONCLUSIONS: Final infarct volume was the strongest predictor of increased hospitalization costs in anterior circulation large-vessel occlusion stroke. Acute stroke therapies that reduce final infarct volume may not only improve clinical outcomes but may also prove cost-effective.


  • Top Cited Papers

    A Systematic Literature Review of Patients With Carotid Web and Acute Ischemic Stroke

    by Andrew J. Zhang, Parth Dhruv, Philip Choi, Caitlin Bakker, Jonathan Koffel, David Anderson, Jae Kim, Bharathi Jagadeesan, Bijoy K. Menon, Christopher Streib

    Background and Purpose—: Carotid web (CW) is a rare form of focal fibromuscular dysplasia defined as an abnormal shelf-like projection of intimal fibrous tissue into the carotid bulb. It is theorized that CW leads to ischemic stroke secondary to blood flow stasis and subsequent embolization. The natural history and optimal management of CW are unclear. To address this knowledge gap, we performed a systematic literature review (SLR) of CW. Methods—: Our librarians performed a SLR for CW and related terminology. Patient-level demographics, stroke risk factors, neuroimaging findings, stroke recurrence or stroke free-duration, and treatment modality were extracted. We used descriptive statistics to characterize our results. When specific patient-level metrics were not reported, the denominators for reporting percentage calculations were adjusted accordingly. Results—: Our literature search produced 1150 articles. Thirty-seven articles including 158 patients (median age 46 years [range 16–85], 68% women, 76% symptomatic) met entry criteria and were included in our SLR. Of the symptomatic CW patients: 57% did not have stroke risk factors, 56% who received medical therapy had recurrent stroke (median 12 months, range 0–97), and 72% were ultimately treated with carotid revascularization (50% carotid stenting, 50% carotid endarterectomy). There were no periprocedural complications or recurrent strokes in carotid revascularization patients. Conclusions—: CW leads to ischemic stroke in younger patients without conventional stroke risk factors. We found a high stroke recurrence rate in medically managed symptomatic CW patients, whereas carotid revascularization effectively prevented recurrent stroke. Our findings should be interpreted with caution because of risk of publication and reporting bias.


  • Open Access

    Readmission after spinal cord injury: analysis of an institutional cohort of 795 patients

    by Chester K. Yarbrough, Paul G. Gamble, Muhammad Burhan Janjua, Mengxuan Tang, Rahel Ghenbot, Andrew J. Zhang, Neringa Juknis, Ammar H. Hawasli, Michael P. Kelly, Wilson Z. Ray

    Article: Readmission after spinal cord injury: analysis of an institutional cohort of 795 patients - Journal of Neurosurgical Sciences 2018 June;62(3):265-70 - Minerva Medica - Journals


  • Open Access

    The Electrophysiologic Effects of Acute Mitral Regurgitation in a Canine Model

    by Christopher P. Lawrance, Matthew C. Henn, Jacob R. Miller, Michael A. Kopek, Andrew J. Zhang, Richard B. Schuessler, Ralph J. Damiano


  • Left Ventricular Assist Device Inflow Angle and Pump Positional Change Over Time Adverse Impact on Left Ventricular Assist Device Function

    by Toshinobu Kazui, Andrew Zhang, Jason Greenberg, Akinobu Itoh, Phat L. Tran, Angela D. Keith, Greg A. Ewald, Ralph J. Damiano, Scott C. Silvestry


  • Open Access

    The intracellular domains of Notch1 and 2 are functionally equivalent during development and carcinogenesis

    by Zhenyi Liu, Eric Brunskill, Barbara Varnum-Finney, Chi Zhang, Andrew Zhang, Patrick Y. Jay, Irv Bernstein, Mitsuru Morimoto, Raphael Kopan

    Although Notch1 and Notch2 are closely related paralogs and function through the same canonical signaling pathway, they do contribute to different outcomes in some cell and disease contexts. To understand the basis for these differences we examined in detail mice in which N1ICD and N2ICD were swapped. Our data point to the conclusion that strength (defined here as the ultimate number of intracellular domain molecules reaching the nucleus, integrating ligand-mediated release and nuclear translocation) and duration (half life of NICD/RBPjk/MAML/DNA complexes, integrating cooperativity and stability dependent on shared sequence elements) are the factors that underlies much of the differences between Notch1 and Notch2 in all the contexts we examined including T cell development, skin differentiation and carcinogenesis, the inner ear, the lung, and the retina. We were able to show that phenotypes in the heart, endothelium, and marginal zone B cells are attributed to haploinsufficiency but not intracellular domain composition. Tissue-specific differences in NICD stability were most likely caused by alternative scissile bond choices by tissue specific γ-secretase complexes following the ICD swap. Reinterpretation of clinical finding based on our analyses suggests that differences in outcome segregating with Notch1 or Notch2 are likely to reflect outcomes dependent on the overall strength of Notch signals.


  • The Extracellular Domain of Notch2 Increases Its Cell-Surface Abundance and Ligand Responsiveness during Kidney Development

    by Zhenyi Liu, Shuang Chen, Scott Boyle, Yu Zhu, Andrew Zhang, David R. Piwnica-Worms, Ma. Xenia G. Ilagan, Raphael Kopan